Not exact matches
As pressure mounted over the
pharmaceutical giant's
rising insulin prices, investors drove its
stock down by a third, fearing that policymakers would cap price tags and hurt profits.
Ironwood Pharma May Satisfy Activist Denner with Split - up Plan, but He Still Seeks Board Seat (CNBC) Ironwood
Pharmaceuticals»
stock rose Tuesday after the company said...
And winning our bronze medal was Crista Huff, chief analyst of Cabot Undervalued
Stocks Advisor, who chose Vertex
Pharmaceuticals (VRTX), which
rose 83.76 %.